Although it is hypothesized that superior efficacy of pemetrexed in non-squamous over squamous NSCLC is related to the level of TS expression, multiple clinical studies failed to demonstrate the association between TS protein expression and clinical outcomes [22, 25]. This evidence concerns the gene TYMS and non-small cell lung carcinoma.